Update on Acquistion of 100% equity shares of HSDL Innovative Private Limited. This is to inform you that the Company has completed acquisition of 100% paid up equity share capital of HSDL ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Hamps Bio Limited has completed the acquisition of 100% paid-up equity share capital of HSDL Innovative Private Limited, making it a Wholly Owned Subsidiary (WOS) effective March 25, 2026. The total purchase consideration was ₹2.04 crore, paid entirely in cash by purchasing shares from the existing shareholder. This is an update to the company's earlier announcement dated February 14, 2026. The acquisition was carried out under Regulation 30 of SEBI Listing Regulations, with prior disclosures already shared with stock exchanges.
HSDL Innovative is now a wholly owned subsidiary of Hamps Bio, potentially expanding its business footprint. However, given the relatively small deal size of ₹2.04 crore, the immediate financial impact on Hamps Bio's overall operations is likely limited.